Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity

Low-dose tolerance therapy with nucleosomal histone peptide epitopes blocks lupus disease in mouse models, but effect in humans is unknown. Herein, we found that CD4+CD25highFoxP3+ or CD4+CD45RA+FoxP3low T-cells, and CD8+CD25+FoxP3+ T-cells were all induced durably in PBMCs from inactive lupus patie...

Full description

Saved in:
Bibliographic Details
Published inClinical immunology (Orlando, Fla.) Vol. 149; no. 3; pp. 365 - 378
Main Authors Zhang, Li, Bertucci, Anne M., Ramsey-Goldman, Rosalind, Harsha-Strong, Elizabeth Randall, Burt, Richard K., Datta, Syamal K.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.12.2013
Subjects
TSA
H
SLE
RA
DEX
HCQ
APG
ODN
LAP
Online AccessGet full text

Cover

Loading…